TQH -T3. Ep.15: Pildora contra COVID-19: Todo sobre su distribución en Perú

from TENEMOS QUE HABLAR · host DIARIO EL COMERCIO

Molnupiravir es el antiviral desarrollado por la farmacéutica MSD para el tratamiento contra casos severos del COVID-19. Hace unos días, la Digemid otorgó el registro sanitario condicional. ¿Qué se sabe sobre la eficacia de esta pastilla ¿Está admitida para la venta en nuestro país?See omnystudio.com/listener for privacy information.

NOW PLAYING

0:00 12:20

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TENEMOS QUE HABLAR?

This episode is 12 minutes long.

When was this TENEMOS QUE HABLAR episode published?

This episode was published on February 21, 2022.

What is this episode about?

Can I download this TENEMOS QUE HABLAR episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.

URL copied to clipboard!